Rockwell Medical agrees to buy Vantive’s hemodialysis assets for $125 million
RMTI•Rockwell Medical agreed to acquire Vantive’s hemodialysis equipment, concentrates and related services business for a $125 million base price, with up to $45 million in contingent consideration. The deal is expected to close in mid-2027, and the buyer withdrew its 2026 financial guidance because of projected transaction and financing expenses.
1. Deal terms and timing
The acquisition includes a manufacturing campus in Medolla, Italy. Financing comprises two $50 million term loans and a $25 million convertible note, while contingent consideration could reach $45 million. The combined business is projected to generate annual revenue of $400 million to $450 million. Closing is expected in mid-2027, subject to regulatory approvals and other conditions.
2. Guidance withdrawn
Rockwell Medical withdrew its 2026 financial guidance because of projected transaction and financing expenses.
